Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
US5990111A · kind A · utility
8Cited by
8References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 1, 1998 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | May 1, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of aldose reductase inhibitors in the treatment, prevention or reversal of diabetic cardiomyopathy in a human subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.